Skip to main content
James Januzzi Jr., MD, Cardiology, Boston, MA, Massachusetts General Hospital

JamesLouisJanuzziJr.MD

Cardiology • Boston, MA

Heart Failure & Transplantation, Non-Invasive Cardiology

Hutter Family Professor of Medicine, Harvard Medical School and Senior Staff Physician in Medicine Massachusetts General Hospital.

Join to view full profile

Dr. Januzzi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Januzzi's full profile

Already have an account?

Summary

  • Dr. James Januzzi is a cardiologist in Boston, MA and is affiliated with Massachusetts General Hospital. He received his medical degree from New York Medical College and has been in practice 23 years. He also speaks multiple languages, including Italian. He specializes in adult general cardiology, with a focus on heart failure, coronary artery disease and myocardial infarction.

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Cardiovascular Disease, 2000
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1994 - 1997
  • Brigham and Women's Hospital
    Brigham and Women's HospitalInternship, Internal Medicine, 1994 - 1995
  • New York Medical College
    New York Medical CollegeClass of 1994
  • College of the Holy Cross
    College of the Holy CrossB.A., Biology, 1984 - 1988

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1996 - 2024

Awards, Honors, & Recognition

  • Top 1% Most Cited Researcher Internationally Clarivate, Inc, 2017
  • Simon Dack Award American College of Cardiology, 2013
  • Elite Reviewer European Heart Journal, 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effects of Canagliflozin on Amino-Terminal Pro–B-type Natriuretic Peptide Implications for Cardiovascular Risk Reduction  
    James Januzzi Jr., MD, JACC: Cardiovascular Imaging
  • The Need to Innovate and Accelerate Clinical Trial Performance BeAT the Clock  
    James Januzzi Jr., MD, JACC: Cardiovascular Imaging
  • Heart Failure Epidemiology in Patients with Diabetes Mellitus Without Coronary Heart Disease  
    James L Januzzi, Darren K Mcguire, Javed Butler, Journal of Cardiac Failure
  • Join now to see all

Books/Book Chapters

  • Pocket Primary Care: A Massachusetts General Hospital Handbook 
    Chapter: Atrial fibrillation and flutter 
    Nakamura K, Stefanescu AEditors: Kiefer MM, Chong CR.Lippincott, Williams and Wilkins, Philadelphia, PA2014
  • Pocket Primary Care: A Massachusetts General Hospital Handbook 
    Chapter: Chest pain and non-invasive testing 
    Nakamura K, Stefanescu AEditors: Kiefer MM, Chong CR.Lippincott, Williams and Wilkins, Philadelphia, PA2014
  • Pocket Primary Care: A Massachusetts General Hospital Handbook 
    Chapter: Dyslipidemia 
    Nakamura K, Stefanescu AEditors: Kiefer MM, Chong CR.Lippincott, Williams and Wilkins, Philadelphia, PA2014
  • Join now to see all

Abstracts/Posters

  • Utility of Soluble ST2 Concentrations for the Evaluation of Dyspneic Patients
    Januzzi JL, American Heart Association Meetings, Chicago IL, 1/1/2006

Lectures

  • Featured Clinical Research III 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Changing Paradigm in Cardiovascular Risk Reduction in Diabetes 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Changing Paradigm in Cardiovascular Risk Reduction in Diabetes 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
  • Join now to see all

Other

Authored Content

  • Heart Failure Biomarkers in COVID-19July 2020
  • Heart Failure Biomarkers in COVID-19July 2020
  • The Need to Innovate and Accelerate Clinical Trial Performance BeAT the ClockJuly 2020
  • Heart Failure Epidemiology in Patients with Diabetes Mellitus Without Coronary Heart DiseaseNovember 2018
  • Prevalent and Incident Heart Failure in Cardiovascular Outcome Trials of Patients with Type 2 DiabetesMarch 2018
  • Evaluating Chest Pain in the Emergency Department Searching for the Optimal GatekeeperFebruary 2018
  • Evaluating Chest Pain in the Emergency Department Searching for the Optimal GatekeeperFebruary 2018
  • Addition or Removal of Guideline Directed Medical Therapy in Ambulatory Patients with Heart Failure with Reduced Ejection Fraction Relative to Change in Symptom Severity: An Analysis from the PINNACLE (Practice Innovation and Clinical Excellence) Registry®January 2018
  • Evolution of Natriuretic Peptide Biomarkers in Heart Failure: Implications for Clinical Care and Clinical Trials☆January 2018
  • Addition or Removal of Guideline Directed Medical Therapy in Ambulatory Patients with Heart Failure with Reduced Ejection Fraction Relative to Change in Symptom Severity: An Analysis from the PINNACLE (Practice Innovation and Clinical Excellence) Registry®January 2018
  • 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure with Reduced Ejection Fraction A Report of the American College of Cardiology Task Force on Expert Consensus Decision PathwaysJanuary 2018
  • 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure with Reduced Ejection Fraction A Report of the American College of Cardiology Task Force on Expert Consensus Decision PathwaysJanuary 2018
  • 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure with Reduced Ejection FractionDecember 2017
  • 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure TreatmentDecember 2017
  • Join now to see all

Press Mentions

  • Massachusetts’s General Hospital Study Demonstrates Prevencio’s AI-Driven HART CVE Blood Test Highly Accurate for Predicting Major Cardiac Events in Patients with Chronic Kidney Disease
    Massachusetts’s General Hospital Study Demonstrates Prevencio’s AI-Driven HART CVE Blood Test Highly Accurate for Predicting Major Cardiac Events in Patients with Chronic Kidney DiseaseNovember 3rd, 2022
  • Massachusetts’s General Hospital Study Demonstrates Prevencio’s AI-Driven HART CVE Blood Test Highly Accurate for Predicting Major Cardiac Events in Patients with Chronic Kidney Disease
    Massachusetts’s General Hospital Study Demonstrates Prevencio’s AI-Driven HART CVE Blood Test Highly Accurate for Predicting Major Cardiac Events in Patients with Chronic Kidney DiseaseNovember 3rd, 2022
  • Prevencio's AI Blood Test Predicts Cardiovascular Risk One Year Out for People with Diabetes: Study
    Prevencio's AI Blood Test Predicts Cardiovascular Risk One Year Out for People with Diabetes: StudyApril 13th, 2022
  • Join now to see all

Committees

  • Trustee, Board of Trustees, American College of Cardiology 2018 - Present

Professional Memberships

Other Languages

  • Italian

Hospital Affiliations

Dr. James Januzzi, Dr. James Januzzi, MD, Dr. J Januzzi, Dr. James Louis Januzzi